文献速递小儿神经外科与脑积水神经重症

Miethke M.scio装置植入用于脑脊液疾病患者颅内压监测的评估

Evaluation of Miethke M.scio Device Implantation for Intracranial Pressure Monitoring in Patients with Cerebrospinal Fluid Disorders.
PubMed 文献 · World Neurosurg · 2023-07-26

2016年6月至2021年8月,14例大于18岁的不同诊断脑脊液疾病患者在接受脑室腹腔分流术时植入Miethke M.scio传感器。术后共进行25次测量,其中11次导致分流设置调整。作者认为该装置安全且有价值,未来研究应包括标准化方案。

要点

  • 14例脑脊液疾病患者接受脑室腹腔分流术并植入Miethke M.scio传感器。
  • 术后共25次颅内压测量,其中11次导致分流设置调整。
  • 作者认为该装置安全且有价值,未来研究需标准化方案。

核心结论

  • Miethke M.scio是用于分流治疗患者的安全且有价值的装置,尤其适用于预期术后需要评估颅内压监测的患者。
  • 重复颅内压测量可协助个体化调整分流设置以优化脑脊液流动。
  • 未来研究应包括标准化方案,将颅内压测量与症状及脑脊液障碍原因相关联。

研究设计与样本

  • 2016年6月至2021年8月的病例系列,纳入14例大于18岁的不同诊断脑脊液疾病患者,接受脑室腹腔分流术并植入Miethke M.scio传感器。

主要发现

  • 患者诊断包括特发性颅内高压(n=3)、肿瘤所致梗阻性脑积水(n=4)和畸形(n=5)。
  • 术前最常见症状为头痛(71%)和视力损害(50%),术后65%的症状改善。
  • 共进行25次测量,其中11次导致分流设置调整。
  • 术后8例患者进行了测量,最常见的颅内压测量指征为头痛和/或分流设置控制。

临床怎么用

  • 作者认为Miethke M.scio是用于分流治疗患者的安全且有价值的装置,尤其适用于预期术后需要评估颅内压监测的患者。
  • 作者认为重复颅内压测量可协助个体化调整分流设置以优化脑脊液流动。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with complex shunt-related problems and varying diagnoses of cerebrospinal fluid (CSF) disturbance can present with headache and clinical symptoms that may be difficult to relate to underdrainage or overdrainage. Telemetric intracranial pressure (ICP) monitoring may assist in evaluating individual patients and assessing shunt function and adjustment. We report a case series of patients receiving a Miethke M.scio sensor. METHODS: Between June 2016 and August 2021, 14 patients older than 18 years with different diagnoses underwent ventriculoperitoneal shunt surgery and received a Miethke M.scio sensor. RESULTS: Patients had idiopathic intracranial hypertension (n = 3), obstructive hydrocephalus caused by tumors (n = 4), and malformations (n = 5). Headaches (71%) and visual impairment (50%) were the most common symptoms before surgery and 65% of the symptoms were improved after surgery. In total, 25 measurements were made and 11 of these led to changes in the shunt settings. Postoperative measurements were taken in 8 patients and the most common indication of ICP measurement was headache and/or control of the shunt settings. CONCLUSIONS: The Miethke M.scio is a safe and valuable device to use in shunt-treated patients, in particular those expected to need assessment of ICP monitoring postoperatively. Repeated ICP measurements can also assist in personalized adjustment of the shunt setting to optimize CSF flow in this diverse patient group. Future studies should include a standardized protocol with ICP measurements correlated to the symptoms and cause of CSF disturbances to provide better understanding of the dynamics of the ICP in each patient.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Jirlow U, Arvidsson L, Magneli S, et al. Evaluation of Miethke M.scio Device Implantation for Intracranial Pressure Monitoring in Patients with Cerebrospinal Fluid Disorders. World Neurosurg. 2023. PMID: 37506838. doi:10.1016/j.wneu.2023.07.102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。